Plasma apolipoprotein A-I, apolipoprotein B, and lipoprotein(a) concentrations in normoglycemic Hispanics and non-Hispanic whites from the San Luis Valley, Colorado.

Lower levels of plasma apolipoprotein (apo) A-I and higher levels of apoB, lipoprotein(a) (Lp(a)), and the ratio of apoB to apoA-I are considered to be independent risk factors for coronary heart disease. To examine race differences in the distributions of plasma levels of apoA-I, apoB, and Lp(a), the authors have determined quantitative levels of these traits in 252 nondiabetic Hispanics and 459 nondiabetic non-Hispanic whites (NHWs) from the San Luis Valley, Colorado. Hispanic men and women, respectively, had significantly higher plasma apoB levels (p < 0.003; p < 0.01) and the ratio of apoB to apoA-I (p < 0.003; p < 0.0003) than their NHW counterparts. Plasma Lp(a) concentrations were also significantly higher in Hispanic men (p < 0.003) and apoA-I levels were significantly lower in Hispanic women (p < 0.0003) than NHW men and women, respectively. Overall, the threshold points of apoA-I (< 120 mg/dl), apoB (> 120 mg/dl), and Lp(a) (> 25 mg/dl) were higher in Hispanics than in NHWs for apoA-I (22.8 vs. 15.7%), apoB (16.9 vs. 9.9%), and Lp(a) (18.6 vs. 12.4%). These data suggest that the quantitative risk profile for coronary heart disease with respect to these three quantitative traits is not favorable for Hispanics compared with that for NHWs in the San Luis Valley, Colorado.

[1]  G. Cazzolato,et al.  ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS? , 1979, The Lancet.

[2]  N. Morton,et al.  Lp(a) lipoprotein as a risk factor for myocardial infarction. , 1986, JAMA.

[3]  R. Hamman,et al.  Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. , 1989, American journal of epidemiology.

[4]  A. Zinsmeister,et al.  Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease. , 1983, The New England journal of medicine.

[5]  K. Matthews,et al.  Menopause and Risk Factors for Coronary Heart Disease , 1989 .

[6]  P. Wilson,et al.  Effects of Age, Sex, and Menopausal Status on Plasma Lipoprotein(a) Levels The Framingham Offspring Study , 1993, Circulation.

[7]  L. Fried,et al.  Cholesterol, lipoproteins, and coronary heart disease in women. , 1988, Clinical chemistry.

[8]  F. Kronenberg,et al.  Lipoprotein(a) in stored plasma samples and the ravages of time. Why epidemiological studies might fail. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[9]  S. Srinivasan,et al.  Serum apolipoproteins A-I and B as markers of coronary artery disease risk in early life: the Bogalusa Heart Study. , 1995, Clinical chemistry.

[10]  P. Wahl,et al.  Quantitation of apolipoprotein A-I of human plasma high density lipoprotein. , 1976, Metabolism: clinical and experimental.

[11]  C. Shear,et al.  The relation of apolipoproteins A-I and B in children to parental myocardial infarction. , 1986, The New England journal of medicine.

[12]  S. Shapiro,et al.  Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Crosignani,et al.  Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women , 1991, The Lancet.

[14]  P. Wilson,et al.  Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study. , 1996, Clinical chemistry.

[15]  K. Cianflone,et al.  Measurement of apoproteins: time to improve the diagnosis and treatment of the atherogenic dyslipoproteinemias. , 1996, Clinical chemistry.

[16]  S. Srinivasan,et al.  Racial (Black‐White) Differences in Serum Lipoprotein (a) Distribution and Its Relation to Parental Myocardial Infarction in Children: Bogalusa Heart Study , 1991, Circulation.

[17]  B E Sobel,et al.  Plasma apoproteins and the severity of coronary artery disease. , 1986, Circulation.

[18]  G. Dagenais,et al.  Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec cardiovascular study. , 1996, Circulation.

[19]  G. Thompson Apoproteins: determinants of lipoprotein metabolism and indices of coronary risk. , 1984, British heart journal.

[20]  G. Assmann,et al.  Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. , 1990, Clinical chemistry.

[21]  S. Haffner,et al.  Lipoprotein(a) concentrations in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study. , 1992, American journal of epidemiology.

[22]  A. Gotto,et al.  CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography , 2022 .

[23]  M. Rewers,et al.  Is the risk of coronary heart disease lower in Hispanics than in non-Hispanic whites? The San Luis Valley Diabetes Study. , 1993, Ethnicity & disease.

[24]  D. Jacobs,et al.  Concentrations of Lp(a) in black and white young adults: relations to risk factors for cardiovascular disease. , 1994, Annals of epidemiology.

[25]  J. F. Barnes,et al.  Lipoprotein (a) concentrations in postmenopausal women taking norethisterone. , 1991, BMJ.

[26]  D. Hewett‐Emmett,et al.  Lipoprotein and apolipoprotein levels among Mexican-Americans in Starr County, Texas. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[27]  A. Zinsmeister,et al.  Apolipoproteins and coronary artery disease. , 1986, Mayo Clinic proceedings.

[28]  D. Thelle,et al.  The Tromsø Heart Study: Serum apolipoprotein Al concentration in relation to future coronary heart disease , 1978, European journal of clinical investigation.

[29]  P. Nestel,et al.  Lipoprotein predictors of the severity of coronary artery disease in men and women. , 1985, Circulation.